Genomind, a leader in precision medicine and pharmacogenomic (PGx) testing, today announced it has been awarded a contract to support the Defense Health Agency’s (DHA) Research & Engineering (R&E) ...
Expanded testing panel provides a better understanding of a patient’s genetic medication risk profile. Genomind’s real-time, interactive, medication management tool GenMedPro™ has expanded to include ...
GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the ...
MOORESTOWN, N.J.--(BUSINESS WIRE)--Cosán, a provider of technology-driven preventative care services for older adults and the physicians that support them, and Genomind, a leading precision healthcare ...
Genomind’s pharmacogenetic testing, which is transforming the landscape of precision medicine, uses a simple cheek swab to assess genes that influence drug metabolism, tolerability, and efficacy. The ...
A psychiatry group affiliated with Fort Wayne, Ind.-based Parkview Health has integrated a genetic testing app into its Epic EHR. Providers with Parkview Physicians Group Psychiatry are now using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results